Back to School: How biopharma can reboot drug development. Access exclusive analysis here

InterMune, KDL GmbH, Marnac deal

Marnac and KDL sold worldwide rights to patents covering pirfenidone to ITMN for $13.5

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE